| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361658 2-acylaminothiazole derivative or salt thereof |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361449 Specific dye compound, optical information recording medium comprising specific dye, and information recording method using this optical information recording medium |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/17/2008 | WO2008045978A1 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 04/17/2008 | WO2008045777A2 A process for the preparation of benzimidazole derivatives and their salts |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044688A1 Urea derivative |
| 04/17/2008 | WO2008044244A2 One pot process for the preparation of candesartan |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008043456A1 Benzoylpyrazoles, their use as as herbicides, and intermediates |
| 04/17/2008 | WO2008043183A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/17/2008 | WO2008027385A3 Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole |
| 04/17/2008 | WO2008022164A3 Pyrazine compounds, their use and methods of preparation |
| 04/17/2008 | WO2008022046A3 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 04/17/2008 | WO2008020302A3 Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
| 04/17/2008 | WO2008010061A3 3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |
| 04/17/2008 | WO2007085895A3 Fap inhibitors |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080091033 React polymethine ether with p-toluenesulfonic acid; powder X-ray diffraction pattern peaks between 11.7 and 27.5 at 2 theta +-0.2 degrees; good stability in solution, high gram extinction coefficient, excellent storage stability, easy to handle, highly sensitive to general-purpose semiconductor lasers |
| 04/17/2008 | US20080091029 5-nitrotetrazolate ligand and cations of alkai, alkali earth metal, triaminoguanidinium, hydrazinium, ammonium and transition metals in plus-two oxidation state; stoichiometric equivalents of the reactants lead to high yields of pure compositions thereby avoiding dangerous purification steps |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090872 AMPA and NMDA receptor modulators; depression, epilepsy, schizophrenia, Alzheimer's, disease, learning and memory disorders, and mild cognitive impairment; 5,1',5'-trimethyl-2'-phenyl-1',2'-dihydro-2H-[3,4']bipyrazolyl-3'-one for example |
| 04/17/2008 | US20080090836 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 04/17/2008 | US20080090818 (4-Morpholin-4-yl-phenyl)-[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]-amine; mitogen-activated protein kinase and matrix metallo proteinase inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090809 Pyrazole compounds |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090802 2-[2-(3-Chlorophenyl)-4-oxo-6-perhydro-1,4-diazepin-1-yl-4H-quinazolin-3-yl]-N-isopropylacetamide; hypothalamo-pituitary-adrenal (HPA) axis stress relieving agent; adrenocorticotropic hormone (ACTH)/ glucocorticoid antagonist; psychological and bipolar disorders, schizophrenia, psychosis, hyperactivity |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090796 Useful in the treatment of neurological and psychiatric disorders associated with glutamatergic neurotransmission dysfunction and diseases; schizophrenia; 2,4-dichloro-N-{[4-(cyclopropylmethyl)-1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl]methyl}benzamide |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | CA2675511A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | CA2666347A1 Benzoylpyrazoles, their use as herbicides, and intermediates |
| 04/17/2008 | CA2666275A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/16/2008 | EP1911755A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 04/16/2008 | EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910497A2 Compositions and methods for coupling a plurality of compounds to a scaffold |
| 04/16/2008 | EP1910385A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 04/16/2008 | EP1910384A1 Imidazo [2,1-b]thiayole derivatives as sirtuin modulating compounds |
| 04/16/2008 | EP1910362A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 04/16/2008 | EP1910344A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910341A2 Inhibitors of serine proteases |
| 04/16/2008 | EP1910340A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 04/16/2008 | EP1910339A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910338A2 Heterotetracyclic compounds as tpo mimetics |
| 04/16/2008 | EP1910335A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 04/16/2008 | EP1910316A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 04/16/2008 | EP1910314A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 04/16/2008 | EP1910302A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 04/16/2008 | EP1910300A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910251A1 Method for isolating 5-substituted tetrazoles |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | CN101163705A Combination product |
| 04/16/2008 | CN101163697A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/16/2008 | CN101163696A Histone deacetylase inhibitors |
| 04/16/2008 | CN101163694A Imidaz0l0-5-yl-2-anil0-pyrimidines as agents for the inhibition of cell proliferation |
| 04/16/2008 | CN101163685A Pharmaceutically active diazepanes |
| 04/16/2008 | CN101163478A Compounds for inflammation and immune-related uses |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/15/2008 | US7358258 Prodrugs of an ERK protein kinase inhibitor |
| 04/15/2008 | US7358253 Indolylmaleimide derivatives |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358246 5-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; contraceptive, menopause; reduces risk of uterine cancers coused by treating with estrogen receptor (ER) agonists |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/15/2008 | US7358014 Charge transport compounds of hydrazone substituted carbazole derivatives, a charge generating compound and electroconductive substrate |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/10/2008 | WO2008042639A1 Compounds and compositions as protein kinase inhibitors |
| 04/10/2008 | WO2008042282A2 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 04/10/2008 | WO2008041957A1 Method for producing pure crystalline form of 2-n-butyl-3-((2-(1h-tetrazole-5-yl) (1,1'-biphenyl)-4-methyl)-1,3-diazapspiro (4,4') non -1- en-4-one |
| 04/10/2008 | WO2008040995A1 Indazoles for use as dpp-iv inhibitors |
| 04/10/2008 | WO2008040950A1 Manufacture of rimcazole |
| 04/10/2008 | WO2008040753A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 04/10/2008 | WO2008040649A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 04/10/2008 | WO2008040492A1 Substituted sulfonamide derivatives |
| 04/10/2008 | WO2008003702A3 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/10/2008 | WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/10/2008 | WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 04/10/2008 | WO2007065662A3 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 04/10/2008 | WO2007060448A3 Chemical process for the preparation of an amido-phenoxybenzoic acid compound |